CTOs on the Move

Wabash County Hospital

www.wchospital.com

 
Wabash County Hospital is a county-owned, critical access hospital. With 25 inpatient beds, we offer critical care services, emergency services, cancer treatment and much more.
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

CareZone

CareZone is a social utility serving individuals and families that care for children, parents or loved ones. CareZone provides a safe, simple, accessible place to organize the information, and coordinate the people and processes involved in caring for someone in need. Co-founded by Jonathan Schwartz and Walter Smith, CareZone is based in San Francisco and Seattle.

APC, Inc.

APC, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Ankeny, IA. To find more information about APC, Inc., please visit www.amerprotcorp.com

Gympass

Gympass is a complete corporate wellbeing platform that ignites every journey to feel good. We`re reinventing wellbeing, making it engaging and accessible. Worldwide companies rely on Gympass` unmatched variety, convenience, and flexibility to support their employees` health and happiness. We partner with best in class wellbeing providers in multiple markets across North America, Latin America, and Europe. With over 50,000 fitness partners, 1,300 on demand classes, 2,000 hours of meditation, 1,000 healthy recipes, weekly 1:1 therapy sessions, and hundreds of personal trainers, Gympass supports every wellbeing journey.

New Mexico Health Connections

New Mexico Health Connections will be a consumer-oriented and operated health plan, governed by experts in health care, consumer protection and medicine.

ForSight VISION5

ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.